| 36822736 | AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. | Gastroenterology | 2023 |
| 35905032 | Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection. | Inflamm Bowel Dis | 2023 |
| 35700276 | Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. | Inflamm Bowel Dis | 2023 |
| 35470286 | Alzheimer Disease Occurs More Frequently In Patients With Inflammatory Bowel Disease: Insight From a Nationwide Study. | J Clin Gastroenterol | 2023 |
| 34825393 | Autoimmune conditions in the World Trade Center general responder cohort: A nested case-control and standardized incidence ratio analysis. | Am J Ind Med | 2022 |
| 35413359 | Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. | Gastroenterology | 2022 |
| 34160735 | Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients. | Digestive Diseases and Sciences | 2022 |
| 33827316 | Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical Home. | J Pharm Pract | 2022 |
| 34798332 | Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and Opioids. | Clinical Gastroenterology and Hepatology | 2022 |
| 35310082 | Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease. | Crohns Colitis 360 | 2022 |
| 34558619 | Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know. | | 2022 |
| 34968729 | Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn's Disease. | Clinical Gastroenterology and Hepatology | 2022 |
| 35190725 | Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. | Nat Med | 2022 |
| 35183108 | Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD. | BMC Gastroenterol | 2022 |
| 33388775 | Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection. | | 2021 |
| 36776639 | Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD. | Crohns Colitis 360 | 2021 |
| 33859104 | Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. | Current Opinion in Gastroenterology | 2021 |
| 34279600 | Health Maintenance Consensus for Adults With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2021 |
| 34052278 | A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease. | Gastroenterology | 2021 |
| 33891004 | Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease. | | 2021 |
| 32629130 | Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2021 |
| 33068786 | Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. | Clin Gastroenterol Hepatol | 2021 |
| 33225766 | Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges. | Expert Review of Gastroenterology and Hepatology | 2021 |
| 30910602 | Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel Diseases. | Clin Gastroenterol Hepatol | 2020 |
| 31639193 | Anastomotic Ulcers After Ileocolic Resection for Crohn's Disease Are Common and Predict Recurrence. | Inflamm Bowel Dis | 2020 |
| 32100018 | Identifying IBD Providers' Knowledge Gaps Using a Prospective Web-based Survey. | Inflammatory Bowel Diseases | 2020 |
| 32820340 | Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. | Inflamm Bowel Dis | 2020 |
| 32584190 | Ileocolic anastomotic inflammation after resection for Crohn's disease indicates disease recurrence: a histopathologic study. | Scand J Gastroenterol | 2020 |
| 32744536 | Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States. | Crohns Colitis 360 | 2020 |
| 31294374 | Inflammatory Bowel Disease Training During Adult Gastroenterology Residency: A National Survey of Canadian Program Directors and Trainees. | | 2019 |
| 31579976 | Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis. | Aliment Pharmacol Ther | 2019 |
| 30666957 | Gut microbiota density influences host physiology and is shaped by host and microbial factors. | Elife | 2019 |
| 30773667 | Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. | Alimentary Pharmacology and Therapeutics | 2019 |
| 31512019 | Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study. | Int J Colorectal Dis | 2019 |
| 28009685 | There is Significant Practice Pattern Variability in the Management of the Hospitalized Ulcerative Colitis Patient at a Tertiary Care and IBD Referral Center. | J Clin Gastroenterol | 2018 |
| 29462380 | Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis. | Inflamm Bowel Dis | 2018 |
| 29688478 | Agreement Between Crohn's Disease Endoscopic Severity Scores Derived from Live, Video-recorded, and Central Readings. | Inflamm Bowel Dis | 2018 |
| 28110094 | Colonic Pseudopolyps Resulting in Iron Deficiency Anemia. | Clin Gastroenterol Hepatol | 2017 |
| 28630047 | Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease. | BMJ, The | 2017 |
| 28365918 | The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships. | Dig Dis Sci | 2017 |
| 27618504 | Reply. | Inflamm Bowel Dis | 2016 |
| 25956836 | Features of Patients With Crohn's Disease and Hidradenitis Suppurativa. | Clin Gastroenterol Hepatol | 2016 |
| 27306068 | State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey. | Inflamm Bowel Dis | 2016 |
| 27167574 | Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States. | Inflamm Bowel Dis | 2016 |
| 26499929 | Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases. | Clin Gastroenterol Hepatol | 2016 |
| 25811432 | A review of the impact of biologics on surgical complications in Crohn's disease. | Inflammatory Bowel Diseases | 2015 |
| 25540149 | High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy. | J Crohns Colitis | 2015 |
| 24612278 | Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. | Aliment Pharmacol Ther | 2014 |
| 25267394 | Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy. | Aliment Pharmacol Ther | 2014 |
| 24343127 | Characteristics and impact of methamphetamine use in patients with chronic hepatitis C. | J Addict Med | 2014 |